Analysts think MURA stock price could increase by 97%
May 15, 2025, 11:25 AM
-4.44%
What does MURA do
Mural Oncology Plc is a clinical-stage company developing cytokine-based immunotherapies for cancer using its protein engineering platform. Its portfolio includes Nemvaleukin alfa and a tumor-targeted split IL-12 program.
4 analysts think MURA stock price will increase by 96.91%. The current median analyst target is $5.10 compared to a current stock price of $2.59. The lowest analysts target is $4.04 and the highest analyst target is $6.30.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
